BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:53:00 PM | Browse: 1470 | Download: 1613
 |
Received |
|
2013-02-25 19:38 |
|
Peer-Review Started |
|
2013-02-26 15:18 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-03-20 08:18 |
|
Revised |
|
2013-03-26 17:22 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-06-06 09:21 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-06-06 12:59 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-08-09 09:58 |
|
Publish the Manuscript Online |
|
2013-08-27 16:46 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cristian Cerda, Miguel Bruguera and Albert Parés |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Miguel Bruguera, Professor, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clínic, Villarroel 270, 08036 Barcelona, Spain. bruguera@clinic.ub.es |
| Key Words |
Toxic hepatitis; Hepatotoxicity; Glucosamine; Chondroitin sulphate; Osteoarthritis |
| Core Tip |
A questionnaire was given to 151 consecutive patients with chronic liver disease of different etiology (mean age 59 years, 56.9% women) attended in an outpatient clinic with the aim of evaluating the frequency of consumption of these drugs and determine whether their use coincided with a worsening in liver function test results. Twenty-three patients (15.2%) recognized having taken products containing glucosamine or chondroitin sulfate previously or at the time of the questionnaire. |
| Publish Date |
2013-08-27 16:46 |
| Citation |
Cerda C, Bruguera M, Parés A. Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease. World J Gastroenterol 2013; 19(32): 5381-5384 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i32/5381.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i32.5381 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
